Position in NAMS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,257,074
+$1,085,508 QoQ
Shares Held
66,600
+82.0% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#93
of 198 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pavaki Capital Management LLC holds $44,033,947 across 21 Biotechnology names. NAMS ranks #8 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIST |
Milestone Pharmaceuticals Inc.
|
9,067,848 | $12,150,916 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,900 | $6,173,046 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
187,000 | $4,903,140 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
579,600 | $4,642,596 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
11,100 | $3,508,599 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
73,000 | $2,657,930 | |
| 7 | RPRX |
Royalty Pharma plc
|
44,000 | $2,467,080 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
66,600 | $2,257,074 |
All Filings in NAMS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,257,074 | 66,600 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,171,566 | 36,600 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||